CFH and hepatocellular carcinoma: Meanwhile, focusing on the EV-protein cargoes, HCC-derived-EV-CD147 and EV-complement factor H constitute tumor-promoting EVs, with the former interacting with fibroblast activation, while the latter with enhancing of inflammatory reaction and HCC progression via the overproduction of complement 5a and 3a [112,113,114,116].